Bull D A, Neumayer L A, Venerus B J, Putnam C W, Rosado L, Lund P, McIntyre K E, Bernhard V M, Copeland J G, Sethi G K
Department of Surgery, University of Utah, Salt Lake City.
J Vasc Surg. 1994 Oct;20(4):539-44; discussion 544-5. doi: 10.1016/0741-5214(94)90278-x.
Retrospective studies have demonstrated an accelerated growth rate of abdominal aortic aneurysms in heart transplant patients. This prospective study was undertaken to define the relationship between cardiac hemodynamics and posttransplant aortic dilation.
Sixty-eight patients undergoing heart (n = 60) or heart-lung (n = 8) transplantation were prospectively evaluated with abdominal ultrasonography before transplantation and annually after transplantation. Risk factors implicated in aneurysm growth, including age, indication for transplantation, immunosuppression, posttransplantation hypertension, and abdominal aortic dimension before transplantation were recorded. All patients underwent annual coronary artery catheterization and multiple gated acquisition scanning.
Thirty-seven patients (54%) had no change in aortic diameter after transplantation (pretransplantation and posttransplantation diameter = 1.8 +/- 0.3 cm), over a mean follow-up period of 28 +/- 14 months. In the remaining 31 (46%) patients, aortic diameter increased by 0.5 +/- 0.6 cm over 31 +/- 15 months (p < 0.05). Four (6%) of these 31 patients had abdominal aortic aneurysms (mean aortic diameter = 5.0 +/- 0.8 cm). The mean increase in aortic diameter among these 4 patients was 1.8 +/- 0.2 cm (annual rate of growth = 0.96 +/- 0.3 cm/year). Patients experiencing an increase in aortic dimension after transplantation had significantly lower (p < 0.005) pretransplantation ejection fractions (17.1% +/- 10.5% vs 28.6% +/- 18.1%) and, as a consequence, significantly greater (p < 0.05) increases in their ejection fractions after transplantation compared with patients with stable aortic dimensions (42.7% +/- 12.6% vs 31.8% +/- 18.0%).
Of 68 heart transplant patients prospectively evaluated, aortic diameter increased in 31 (46%); new aneurysms developed in four of these patients. Greater incremental increases in cardiac ejection fraction were significant correlates with aortic enlargement.
回顾性研究表明,心脏移植患者腹主动脉瘤的生长速度加快。本前瞻性研究旨在确定心脏血流动力学与移植后主动脉扩张之间的关系。
对68例接受心脏移植(n = 60)或心肺移植(n = 8)的患者在移植前进行腹部超声检查,并在移植后每年进行一次前瞻性评估。记录与动脉瘤生长相关的危险因素,包括年龄、移植指征、免疫抑制、移植后高血压以及移植前腹主动脉尺寸。所有患者均接受年度冠状动脉导管插入术和多门控采集扫描。
在平均28±14个月的随访期内,37例患者(54%)移植后主动脉直径无变化(移植前和移植后直径 = 1.8±0.3 cm)。在其余31例(46%)患者中,主动脉直径在31±15个月内增加了0.5±0.6 cm(p < 0.05)。这31例患者中有4例(6%)发生腹主动脉瘤(平均主动脉直径 = 5.0±0.8 cm)。这4例患者的主动脉直径平均增加1.8±0.2 cm(年生长率 = 0.96±0.3 cm/年)。移植后主动脉尺寸增加的患者移植前射血分数显著较低(p < 0.005)(17.1%±10.5%对28.6%±18.1%),因此,与主动脉尺寸稳定的患者相比,移植后射血分数的增加显著更大(p < 0.05)(42.7%±12.6%对31.8%±18.0%)。
在68例接受前瞻性评估的心脏移植患者中,31例(46%)主动脉直径增加;其中4例患者出现新的动脉瘤。心脏射血分数的更大增量增加与主动脉扩大显著相关。